Results 201 to 210 of about 26,607 (237)
Some of the next articles are maybe not open access.

Acute promyelocytic leukemia and pregnancy

European Journal of Haematology, 2000
Abstract: In acute promyelocytic leukemia (APL), the use of all‐trans‐retinoic acid (ATRA) as a differentiating agent induces complete remission in a high percentage of patients. In pregnancy, however, this drug bears the risk of severe teratogenicity to the child. We report the case of a 23‐yr‐old woman at 21 weeks' gestation suffering from APL.
A A, Giagounidis   +8 more
openaire   +2 more sources

History of Acute Promyelocytic Leukemia

2017
Within a 60-year time span, the most severe acute leukemia—termed acute promyelocytic leukemia (APL) by the Norwegian author Leif Hillestad—was identified, characterized, and cured. The determination of a precise molecular definition of the genetic defect and the emergence of an antidogmatic paradigm have made the history of APL a model for the ...
openaire   +2 more sources

Acute promyelocytic leukemia

Best Practice & Research Clinical Haematology, 2014
Acute promyelocytic leukemia (APL) is designated M3 in the French-American-British (FAB) classification. Because of its unique clinical features and unique response to certain differentiation-inducing agents, and because of our advanced understanding of the molecular biology and treatment of this leukemia, APL deserves to be presented and discussed in ...
openaire   +1 more source

Acute Promyelocytic Leukemia

New England Journal of Medicine
Syed Hamza Bin Waqar   +2 more
openaire   +3 more sources

Treatment of Acute Promyelocytic Leukemia

New England Journal of Medicine, 2013
Yuji, Miura   +2 more
openaire   +3 more sources

Acute promyelocytic leukemia, arsenic, and PML bodies

Journal of Cell Biology, 2012
Hugues de The   +2 more
exaly  

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

New England Journal of Medicine, 1998
Steven L Soignet   +2 more
exaly  

Home - About - Disclaimer - Privacy